Amyotrophic Lateral Sclerosis: Exploring the Current & Future Treatment Landscape – Rare Disease Report


Rare Disease Report

Amyotrophic Lateral Sclerosis: Exploring the Current & Future Treatment Landscape
Rare Disease Report
Because of this database, scientists are able to determine that ALS is more common in men than women, that the median survival is about 2 to 3 years from symptom onset, and older-onset might mean a faster rate of disease progression. However, variables …

Source: Brain Injury News

Leave a Reply